MIR100HG and neoplasm: Meanwhile, dysregulated expression of MIR100HG is markedly correlated with poor prognosis and clinicopathological features including tumor size, AJCC stage, TNM stage, LNM, distant metastasis, prognosis, DFS, OS, and chemoresistance (Table 2).